Then, the Breast Cancer Gene-Expression Miner v4.7 resource was employed to confirm the prognostic value of CEMIP, with which we further performed survival analysis in ER/PR-positive BC patients and ER/PR-negative BC patients. This evidence concerns the gene ESR1 and breast carcinoma.